These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 12177659)

  • 1. Effectiveness of a novel serotonin blocker, sarpogrelate, for patients with angina pectoris.
    Kinugawa T; Fujita M; Lee JD; Nakajima H; Hanada H; Miyamoto S
    Am Heart J; 2002 Aug; 144(2):E1. PubMed ID: 12177659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement of exercise capacity by sarpogrelate as a result of augmented collateral circulation in patients with effort angina.
    Tanaka T; Fujita M; Nakae I; Tamaki S; Hasegawa K; Kihara Y; Nohara R; Sasayama S
    J Am Coll Cardiol; 1998 Dec; 32(7):1982-6. PubMed ID: 9857882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sarpogrelate treatment reduces restenosis after coronary stenting.
    Fujita M; Mizuno K; Ho M; Tsukahara R; Miyamoto A; Miki O; Ishii K; Miwa K
    Am Heart J; 2003 Mar; 145(3):E16. PubMed ID: 12660685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sarpogrelate, a 5-HT2 receptor blocker, may have a preconditioning-like effect in patients with coronary artery disease.
    Horibe E; Nishigaki K; Minatoguchi S; Fujiwara H
    Circ J; 2004 Jan; 68(1):68-72. PubMed ID: 14695468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial.
    Chaitman BR; Pepine CJ; Parker JO; Skopal J; Chumakova G; Kuch J; Wang W; Skettino SL; Wolff AA;
    JAMA; 2004 Jan; 291(3):309-16. PubMed ID: 14734593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intermittent transdermal nitroglycerin therapy. Decreased anginal threshold during the nitrate-free interval.
    Parker JD; Parker AB; Farrell B; Parker JO
    Circulation; 1995 Feb; 91(4):973-8. PubMed ID: 7850984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of sarpogrelate and high-dose statin on the reduction of coronary spasm in vasospastic angina: A two by two factorial, pilot randomized study.
    Kim SR; Choi KH; Song YB; Lee JM; Park TK; Yang JH; Hahn JY; Choi JH; Choi SH; Gwon HC
    Clin Cardiol; 2019 Oct; 42(10):899-907. PubMed ID: 31339594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral nitroglycerin as a prophylactic antianginal drug: clinical, physiologic, and statistical evidence of efficacy based on a three-phase experimental design.
    Winsor T; Berger HJ
    Am Heart J; 1975 Nov; 90(5):611-26. PubMed ID: 811102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double-blind, dose-response, placebo-controlled multicenter study of nisoldipine. A new second-generation calcium channel blocker in angina pectoris.
    Thadani U; Zellner SR; Glasser S; Bittar N; Montoro R; Miller AB; Chaitman B; Schulman P; Stahl A; DiBianco R
    Circulation; 1991 Dec; 84(6):2398-408. PubMed ID: 1959195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Collateral circulation during exercise-induced angina: evaluation by coronary angiography].
    Kodama K; Sato H; Nanto S; Naka M; Kimura T; Asada S; Koretsune Y; Mishima M; Inoue M
    J Cardiogr; 1986 Dec; 16(4):851-60. PubMed ID: 3123560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double-blind efficacy and safety study of a novel anti-ischemic agent, ranolazine, versus placebo in patients with chronic stable angina pectoris. Ranolazine Study Group.
    Thadani U; Ezekowitz M; Fenney L; Chiang YK
    Circulation; 1994 Aug; 90(2):726-34. PubMed ID: 8044941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased exercise tolerance after nitroglycerin oral spray: a new and effective therapeutic modality in angina pectoris.
    Kimchi A; Lee G; Amsterdam E; Fujii K; Krieg P; Mason DT
    Circulation; 1983 Jan; 67(1):124-7. PubMed ID: 6401172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of coenzyme Q10 on exercise tolerance in chronic stable angina pectoris.
    Kamikawa T; Kobayashi A; Yamashita T; Hayashi H; Yamazaki N
    Am J Cardiol; 1985 Aug; 56(4):247-51. PubMed ID: 3927692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antianginal efficacy and improved exercise performance with timolol. Twice-daily beta blockade in ischemic heart disease.
    Harris FJ; Low RI; Paumer L; Amsterdam EA; Mason DT
    Am J Cardiol; 1983 Jan; 51(1):13-8. PubMed ID: 6129794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of a new transdermal nitroglycerin patch (Deponit 10) for stable angina pectoris.
    Greco R; D'Alterio D; Schiattarella M; Boccia A; Greco L; Marsico F
    Am J Cardiol; 1988 Mar; 61(9):44E-51E. PubMed ID: 3126635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adaptation to myocardial ischemia during repeated dynamic exercise in relation to findings at cardiac catheterization.
    Ylitalo K; Jama L; Raatikainen P; Peuhkurinen K
    Am Heart J; 1996 Apr; 131(4):689-97. PubMed ID: 8721640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sarpogrelate hydrochloride, a selective 5-HT2A antagonist, improves vascular function in patients with peripheral arterial disease.
    Miyazaki M; Higashi Y; Goto C; Chayama K; Yoshizumi M; Sanada H; Orihashi K; Sueda T
    J Cardiovasc Pharmacol; 2007 Apr; 49(4):221-7. PubMed ID: 17438407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double-blind dose-response study of amlodipine in patients with stable angina pectoris.
    Cocco G; Alfiero R
    Eur Heart J; 1991 Feb; 12(2):169-74. PubMed ID: 1828420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination treatment with trimetazidine and diltiazem in stable angina pectoris.
    Manchanda SC; Krishnaswami S
    Heart; 1997 Oct; 78(4):353-7. PubMed ID: 9404250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of sarpogrelate, a 5-HT(2A) antagonist, on platelet aggregation in patients with ischemic stroke: clinical-pharmacological dose-response study.
    Uchiyama S; Ozaki Y; Satoh K; Kondo K; Nishimaru K
    Cerebrovasc Dis; 2007; 24(2-3):264-70. PubMed ID: 17622759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.